🇺🇸 FDA
Patent

US 6593308

Targeted drug delivery with a hyaluronan ligand

expired A61KA61K47/6911A61K9/1271

Quick answer

US patent 6593308 (Targeted drug delivery with a hyaluronan ligand) held by The Regents of the University of California expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K47/6911, A61K9/1271